The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Cancer Vaccines-Global Market Insights and Sales Trends 2024

Cancer Vaccines-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1855406

No of Pages : 93

Ask Your Query

Synopsis

Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes.

The global Cancer Vaccines market size is expected to reach US$ 12220 million by 2029, growing at a CAGR of 14.3% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Vaccines in various end use industries. The expanding demands from the Cervical Cancer, Prostate Cancer and Others,, are propelling Cancer Vaccines market. Preventive Cancer Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapeutic Cancer Vaccines segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Cancer Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Cancer Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Vaccines sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Vaccines covered in this report include Glaxosmithkline, Astellas Pharma, Merck, CSL Limited, Sanpower Group, Sanofi Pasteur, Pfizer and Serum Institute of India, etc.

The global Cancer Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Glaxosmithkline
  • Astellas Pharma
  • Merck
  • CSL Limited
  • Sanpower Group
  • Sanofi Pasteur
  • Pfizer
  • Serum Institute of India

Global Cancer Vaccines market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Cancer Vaccines market, Segment by Type:

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines

Global Cancer Vaccines market, by Application

  • Cervical Cancer
  • Prostate Cancer
  • Others

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cancer Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cancer Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Cancer Vaccines Market Overview
1.1 Cancer Vaccines Product Overview
1.2 Cancer Vaccines Market Segment by Type
1.2.1 Preventive Cancer Vaccines
1.2.2 Therapeutic Cancer Vaccines
1.3 Global Cancer Vaccines Market Size by Type
1.3.1 Global Cancer Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Cancer Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cancer Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cancer Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cancer Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cancer Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cancer Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cancer Vaccines Sales Breakdown by Type (2018-2023)
2 Global Cancer Vaccines Market Competition by Company
2.1 Global Top Players by Cancer Vaccines Sales (2018-2023)
2.2 Global Top Players by Cancer Vaccines Revenue (2018-2023)
2.3 Global Top Players by Cancer Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Cancer Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Vaccines Market Competitive Situation and Trends
2.5.1 Cancer Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cancer Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Cancer Vaccines Market
2.8 Key Manufacturers Cancer Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cancer Vaccines Status and Outlook by Region
3.1 Global Cancer Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cancer Vaccines Historic Market Size by Region
3.2.1 Global Cancer Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Cancer Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Cancer Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cancer Vaccines Forecasted Market Size by Region
3.3.1 Global Cancer Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Cancer Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Cancer Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cancer Vaccines by Application
4.1 Cancer Vaccines Market Segment by Application
4.1.1 Cervical Cancer
4.1.2 Prostate Cancer
4.1.3 Others
4.2 Global Cancer Vaccines Market Size by Application
4.2.1 Global Cancer Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Cancer Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cancer Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cancer Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cancer Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cancer Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cancer Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cancer Vaccines Sales Breakdown by Application (2018-2023)
5 North America Cancer Vaccines by Country
5.1 North America Cancer Vaccines Historic Market Size by Country
5.1.1 North America Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cancer Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Cancer Vaccines Sales in Value by Country (2018-2023)
5.2 North America Cancer Vaccines Forecasted Market Size by Country
5.2.1 North America Cancer Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Cancer Vaccines Sales in Value by Country (2024-2029)
6 Europe Cancer Vaccines by Country
6.1 Europe Cancer Vaccines Historic Market Size by Country
6.1.1 Europe Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cancer Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Cancer Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Cancer Vaccines Forecasted Market Size by Country
6.2.1 Europe Cancer Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Cancer Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Cancer Vaccines by Region
7.1 Asia-Pacific Cancer Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Cancer Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cancer Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cancer Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cancer Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Cancer Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cancer Vaccines Sales in Value by Region (2024-2029)
8 Latin America Cancer Vaccines by Country
8.1 Latin America Cancer Vaccines Historic Market Size by Country
8.1.1 Latin America Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cancer Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cancer Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Cancer Vaccines Forecasted Market Size by Country
8.2.1 Latin America Cancer Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cancer Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Cancer Vaccines by Country
9.1 Middle East and Africa Cancer Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cancer Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cancer Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cancer Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Cancer Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cancer Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Glaxosmithkline
10.1.1 Glaxosmithkline Company Information
10.1.2 Glaxosmithkline Introduction and Business Overview
10.1.3 Glaxosmithkline Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Glaxosmithkline Cancer Vaccines Products Offered
10.1.5 Glaxosmithkline Recent Development
10.2 Astellas Pharma
10.2.1 Astellas Pharma Company Information
10.2.2 Astellas Pharma Introduction and Business Overview
10.2.3 Astellas Pharma Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Astellas Pharma Cancer Vaccines Products Offered
10.2.5 Astellas Pharma Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Cancer Vaccines Products Offered
10.3.5 Merck Recent Development
10.4 CSL Limited
10.4.1 CSL Limited Company Information
10.4.2 CSL Limited Introduction and Business Overview
10.4.3 CSL Limited Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CSL Limited Cancer Vaccines Products Offered
10.4.5 CSL Limited Recent Development
10.5 Sanpower Group
10.5.1 Sanpower Group Company Information
10.5.2 Sanpower Group Introduction and Business Overview
10.5.3 Sanpower Group Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanpower Group Cancer Vaccines Products Offered
10.5.5 Sanpower Group Recent Development
10.6 Sanofi Pasteur
10.6.1 Sanofi Pasteur Company Information
10.6.2 Sanofi Pasteur Introduction and Business Overview
10.6.3 Sanofi Pasteur Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sanofi Pasteur Cancer Vaccines Products Offered
10.6.5 Sanofi Pasteur Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Cancer Vaccines Products Offered
10.7.5 Pfizer Recent Development
10.8 Serum Institute of India
10.8.1 Serum Institute of India Company Information
10.8.2 Serum Institute of India Introduction and Business Overview
10.8.3 Serum Institute of India Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Serum Institute of India Cancer Vaccines Products Offered
10.8.5 Serum Institute of India Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cancer Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cancer Vaccines Industrial Chain Analysis
11.4 Cancer Vaccines Market Dynamics
11.4.1 Cancer Vaccines Industry Trends
11.4.2 Cancer Vaccines Market Drivers
11.4.3 Cancer Vaccines Market Challenges
11.4.4 Cancer Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cancer Vaccines Distributors
12.3 Cancer Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock